You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,344,479


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,344,479
Title: Method of preventing retinopathy of prematurity in a neonate
Abstract:A method is disclosed of preventing retinopathy of prematurity in a prematurely born neonate susceptible to developing retinopathy of prematurity, which comprises the step of parenterally administering to said prematurely born neonate, a therapeutically effective amount of a water-soluble, pharmaceutically effective salt of ibuprofen as an active ingredient to promote retinal and choroidal blood flow autoregulation in said neonate.
Inventor(s): Van Overmeire; Bart (Antwerp, BE), Darko; Laszlo (Westport, CT)
Assignee: Farmacon-Il, LLC (Westport, CT)
Application Number:09/813,280
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

United States Patent 6,344,479: A Detailed Analysis of Scope and Claims

Introduction

United States Patent 6,344,479, hereafter referred to as the '479 patent, is a significant intellectual property asset that requires a thorough analysis to understand its scope, claims, and position within the patent landscape. This article will delve into the key aspects of this patent, including its background, claims, and the broader context in which it exists.

Background

The '479 patent, like many others, is part of a larger family of patents that often share common ancestry and technological roots. Understanding the background of the patent involves looking at its priority claims, related patents, and the technological field it pertains to.

Patent Family and Priority Claims

The '479 patent may be part of a larger patent family, which includes other patents that claim priority from the same original application or are continuations-in-part of earlier patents. This is similar to the scenario described in the In re Cellect case, where multiple patents were interrelated and claimed priority from a single application[1].

Claims Analysis

Claim Structure

Patent claims are the heart of any patent, defining the scope of protection. The '479 patent would typically include a set of independent and dependent claims. Independent claims stand alone and define the broadest scope of the invention, while dependent claims narrow down the invention by adding additional limitations.

Claim Scope and Breadth

The scope and breadth of patent claims are critical in determining the patent's validity and enforceability. Research has shown that narrower claims at publication are associated with a higher probability of grant and a shorter examination process compared to broader claims[3].

Independent Claim Length and Count

Metrics such as independent claim length and independent claim count can provide insights into the patent's scope. These metrics have been validated as having explanatory power for several correlates of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes[3].

Technological Field

Understanding the technological field in which the '479 patent operates is essential. This involves identifying the industry, the specific technology, and how the patent fits into the broader landscape of similar inventions.

Prior Art and Patent Search

To fully analyze the '479 patent, it is crucial to conduct a thorough prior art search. Tools such as the USPTO's Patent Public Search, Global Dossier, and the Common Citation Document (CCD) can be used to identify relevant prior art and understand how the '479 patent distinguishes itself from existing technology[4].

Patent Term and Adjustments

The patent term and any adjustments due to delays during prosecution are important factors. The '479 patent, like others, may have been granted Patent Term Adjustment (PTA) for USPTO delays during prosecution. This can affect the patent's expiration date and its overall lifespan[1].

Obviousness-Type Double Patenting (ODP)

ODP is a critical issue that can arise in patents, especially those within a family of related patents. The In re Cellect case highlights the importance of ODP analysis, where patents within the same family can be found unpatentable over each other if they do not meet specific criteria[1].

Litigation and Enforcement

The '479 patent's enforceability and any litigation history are vital components of its analysis. This includes looking at any court decisions, reexamination proceedings, or other legal challenges that may have impacted the patent's validity.

Industry Impact and Market Position

Understanding the industry impact and market position of the '479 patent involves analyzing its role in the market, any licensing agreements, and how it affects competitors. This can also include looking at forward citations and the breadth of patent classes to gauge its influence on subsequent innovations[3].

Stakeholder Perspectives

Different stakeholders, including inventors, assignees, and competitors, may have varying perspectives on the '479 patent. For instance, a small claims patent court, as proposed by the Administrative Conference of the United States (ACUS), could potentially impact how disputes related to this patent are resolved[2].

Global Patent Landscape

The '479 patent is not isolated but part of a global patent landscape. Searching international patent offices such as the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO) can provide insights into its global reach and potential conflicts or synergies with other international patents[4].

Key Takeaways

  • Patent Claims: The scope and breadth of claims are crucial for determining the patent's validity and enforceability.
  • Prior Art Search: Conducting a thorough prior art search is essential to understand the patent's novelty and non-obviousness.
  • Patent Term Adjustments: Any adjustments to the patent term due to prosecution delays can impact the patent's lifespan.
  • ODP Analysis: Ensuring that the patent does not fall under obviousness-type double patenting is vital for its validity.
  • Industry Impact: Understanding the patent's role in the market and its impact on competitors is essential for strategic decision-making.

FAQs

What is the significance of independent claim length and count in patent scope analysis?

Independent claim length and count are metrics that help measure patent scope. They have been validated to have explanatory power for several correlates of patent scope, including patent maintenance payments and forward citations[3].

How does the USPTO's Patent Public Search tool aid in patent analysis?

The USPTO's Patent Public Search tool provides enhanced access to prior art, allowing users to identify relevant patents and understand how a given patent distinguishes itself from existing technology[4].

What is obviousness-type double patenting (ODP), and why is it important?

ODP is a doctrine that prevents the issuance of multiple patents for the same invention. It is crucial because it ensures that patents within the same family do not unfairly extend the patent term or create divided ownership issues[1].

How can a small claims patent court impact patent disputes?

A small claims patent court could provide a more streamlined and cost-effective way to resolve patent disputes, particularly for smaller entities that may not have the resources for lengthy and expensive litigation[2].

What resources are available for searching international patents?

Resources such as the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO) provide searchable databases for international patents, helping to understand a patent's global reach and potential conflicts[4].

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit[1]
  2. U.S. Patent Small Claims Court - Administrative Conference of the United States[2]
  3. Patent Claims and Patent Scope - SSRN[3]
  4. Search for patents - USPTO[4]

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,344,479

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.